Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02992483
Brief Title: Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma

First Submitted : December 12, 2016
First Submitted that Met QC Criteria : December 12, 2016
First Posted : December 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 7, 2020
Last Update Posted : February 10, 2020